US

Velocity is collaborating with Merck to explore a new way to engage communities about clinical research. Starting this month the Velocity team members are conducting a tour of several Southern California cities, using Merck’s iLab53, a state-of-the-art, modular 39-foot mobile research unit to reach underserved communities. At each stop, the mobile research unit will serve … Read more

Velocity Clinical Research (“Velocity”), the leading multi-specialty clinical sites business, and Privia Health (Nasdaq: PRVA), a physician enablement company serving more than 3,700 providers and 4.4 million patients, today announced a partnership to open embedded clinical research sites within Privia’s practice network. The partnership is intended to establish integrated research sites within existing Privia Care … Read more